Literature DB >> 29967337

De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.

Sarah A Cumming1, Mark J Hamilton2,3, Yvonne Robb4, Helen Gregory5, Catherine McWilliam6, Anneli Cooper1, Berit Adam1, Josephine McGhie1, Graham Hamilton7, Pawel Herzyk7, Michael R Tschannen8, Elizabeth Worthey8,9, Richard Petty10, Bob Ballantyne11, Jon Warner12, Maria Elena Farrugia10, Cheryl Longman11, Darren G Monckton1.   

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3'-untranslated region of the DMPK gene. The repeat expansion is somatically unstable and tends to increase in length with time, contributing to disease progression. In some individuals, the repeat array is interrupted by variant repeats such as CCG and CGG, stabilising the expansion and often leading to milder symptoms. We have characterised three families, each including one person with variant repeats that had arisen de novo on paternal transmission of the repeat expansion. Two individuals were identified for screening due to an unusual result in the laboratory diagnostic test, and the third due to exceptionally mild symptoms. The presence of variant repeats in all three expanded alleles was confirmed by restriction digestion of small pool PCR products, and allele structures were determined by PacBio sequencing. Each was different, but all contained CCG repeats close to the 3'-end of the repeat expansion. All other family members had inherited pure CTG repeats. The variant repeat-containing alleles were more stable in the blood than pure alleles of similar length, which may in part account for the mild symptoms observed in all three individuals. This emphasises the importance of somatic instability as a disease mechanism in DM1. Further, since patients with variant repeats may have unusually mild symptoms, identification of these individuals has important implications for genetic counselling and for patient stratification in DM1 clinical trials.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29967337      PMCID: PMC6189127          DOI: 10.1038/s41431-018-0156-9

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  45 in total

1.  Analysis of unstable triplet repeats using small-pool polymerase chain reaction.

Authors:  Mário Gomes-Pereira; Sanjay I Bidichandani; Darren G Monckton
Journal:  Methods Mol Biol       Date:  2004

2.  Using Tablet for visual exploration of second-generation sequencing data.

Authors:  Iain Milne; Gordon Stephen; Micha Bayer; Peter J A Cock; Leighton Pritchard; Linda Cardle; Paul D Shaw; David Marshall
Journal:  Brief Bioinform       Date:  2012-03-24       Impact factor: 11.622

Review 3.  Myotonic dystrophy: diagnosis, management and new therapies.

Authors:  Chris Turner; David Hilton-Jones
Journal:  Curr Opin Neurol       Date:  2014-10       Impact factor: 5.710

4.  Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1.

Authors:  Kenji Jinnai; Maki Mitani; Naonobu Futamura; Kunihiko Kawamoto; Itaru Funakawa; Kyoko Itoh
Journal:  Muscle Nerve       Date:  2013-04-29       Impact factor: 3.217

5.  Alternative structures in duplex DNA formed within the trinucleotide repeats of the myotonic dystrophy and fragile X loci.

Authors:  C E Pearson; R R Sinden
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

6.  Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients.

Authors:  Claudia Braida; Rhoda K A Stefanatos; Berit Adam; Navdeep Mahajan; Hubert J M Smeets; Florence Niel; Cyril Goizet; Benoit Arveiler; Michel Koenig; Clotilde Lagier-Tourenne; Jean-Louis Mandel; Catharina G Faber; Christine E M de Die-Smulders; Frank Spaans; Darren G Monckton
Journal:  Hum Mol Genet       Date:  2010-01-15       Impact factor: 6.150

7.  Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.

Authors:  Massimo Santoro; Marcella Masciullo; Roberta Pietrobono; Giulia Conte; Anna Modoni; Maria Laura E Bianchi; Valentina Rizzo; Maria Grazia Pomponi; Giorgio Tasca; Giovanni Neri; Gabriella Silvestri
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

8.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

9.  Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy.

Authors:  M Anvret; G Ahlberg; U Grandell; B Hedberg; K Johnson; L Edström
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

10.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update.

Authors:  Enis Afgan; Dannon Baker; Marius van den Beek; Daniel Blankenberg; Dave Bouvier; Martin Čech; John Chilton; Dave Clements; Nate Coraor; Carl Eberhard; Björn Grüning; Aysam Guerler; Jennifer Hillman-Jackson; Greg Von Kuster; Eric Rasche; Nicola Soranzo; Nitesh Turaga; James Taylor; Anton Nekrutenko; Jeremy Goecks
Journal:  Nucleic Acids Res       Date:  2016-05-02       Impact factor: 16.971

View more
  35 in total

1.  Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.

Authors:  Gayle Overend; Cécilia Légaré; Jean Mathieu; Luigi Bouchard; Cynthia Gagnon; Darren G Monckton
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

Review 2.  Long-read sequencing for rare human genetic diseases.

Authors:  Satomi Mitsuhashi; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-09-27       Impact factor: 3.172

Review 3.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

4.  High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1.

Authors:  Astrid Rasmussen; Mathis Hildonen; John Vissing; Morten Duno; Zeynep Tümer; Ulf Birkedal
Journal:  Genes (Basel)       Date:  2022-05-28       Impact factor: 4.141

5.  Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.

Authors:  Ye Hyun Hwang; Bruce Eliot Hayward; Marwa Zafarullah; Jay Kumar; Blythe Durbin Johnson; Peter Holmans; Karen Usdin; Flora Tassone
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 6.  Applying genomic and transcriptomic advances to mitochondrial medicine.

Authors:  William L Macken; Jana Vandrovcova; Michael G Hanna; Robert D S Pitceathly
Journal:  Nat Rev Neurol       Date:  2021-02-23       Impact factor: 42.937

Review 7.  Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases.

Authors:  Haseeb Nisar; Bilal Wajid; Samiah Shahid; Faria Anwar; Imran Wajid; Asia Khatoon; Mian Usman Sattar; Saima Sadaf
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-15

8.  Identification, molecular characterization and segregation analysis of a variant DMPK pre-mutation allele in a three-generation Italian family.

Authors:  Luana Fontana; Massimo Santoro; Maria Rosaria D'Apice; Francesca Peluso; Giulia Gori; Amelia Morrone; Giuseppe Novelli; Laura Dosa; Annalisa Botta
Journal:  Acta Myol       Date:  2020-03-01

Review 9.  DNA Hypermethylation and Unstable Repeat Diseases: A Paradigm of Transcriptional Silencing to Decipher the Basis of Pathogenic Mechanisms.

Authors:  Loredana Poeta; Denise Drongitis; Lucia Verrillo; Maria Giuseppina Miano
Journal:  Genes (Basel)       Date:  2020-06-22       Impact factor: 4.096

10.  Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1.

Authors:  Jacob N Miller; Ellen van der Plas; Mark Hamilton; Timothy R Koscik; Laurie Gutmann; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos
Journal:  Neurol Genet       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.